Table 1. . Patient demographics and characteristics.
| Baseline characteristic | Total (n = 106) |
|---|---|
| Age (years) | 68.6 ± 9.2 |
| Male | 63 (59.4%) |
| Female | 43 (41.6%) |
| Race: – White – Black – Asian – Unknown |
68 (64.2%) 18 (17.0%) 6 (5.7%) 14 (13.2%) |
| BMI | 25.7 ± 5.4 |
| Smoking status: – Yes – Former |
23 (21.7%) 67 (63.2%) |
| Baseline albumin | 3.9 ± 0.4 |
| Baseline albumin (<3.5 g/dl) | 18 (17%) |
| Malnourished based CNA | 23 (21.7%) |
| Initial ≥5% weight loss upon starting immunotherapy | 40 (37.7%) |
| ECOG PS: – 0 – 1 – 2 – 3 |
18 (17.3%) 51 (49.0%) 26 (25.0%) 9 (8.7%) |
| Line of therapy – First – Second – Third or more |
17 (16.0%) 68 (64.2%) 21 (19.8%) |
| Morphological classification – Adenocarcinoma – Squamous – Small cell |
68 (67.3%) 25 (24.8%) 8 (7.9%) |
| Radiation during immunotherapy | 10 (9.4%) |
| Number of cycles, median (IQR) | 4 (6–12) |
Data represented as n (%) or mean (± SD) unless otherwise stated.
CNA: Composite nutritional assessment; ECOG PS: Eastern Cooperative Group performance status; IQR: Interquartile range; SD: Standard deviation.